| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Lázaro-Ibáñez, Elisa, et al.
(författare)
-
Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines
- 2017
-
Ingår i: Bmc Cancer. - : Springer Science and Business Media LLC. - 1471-2407. ; 17:92
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Multiple types of extracellular vesicles (EVs), including microvesicles (MVs) and exosomes (EXOs), are released by all cells constituting part of the cellular EV secretome. The bioactive cargo of EVs can be shuffled between cells and consists of lipids, metabolites, proteins, and nucleic acids, including multiple RNA species from non-coding RNAs to messenger RNAs (mRNAs). In this study, we hypothesized that the mRNA cargo of EVs could differ based on the EV cellular origin and subpopulation analyzed. Methods: We isolated MVs and EXOs from PC-3 and LNCaP prostate cancer cells by differential centrifugation and compared them to EVs derived from the benign PNT2 prostate cells. The relative mRNA levels of 84 prostate cancer-related genes were investigated and validated using quantitative reverse transcription PCR arrays. Results: Based on the mRNA abundance, MVs rather than EXOs were enriched in the analyzed transcripts, providing a snapshot of the tumor transcriptome. LNCaP MVs specifically contained significantly increased mRNA levels of NK3 Homeobox 1 (NKX3-1), transmembrane protease serine 2 (TMPRSS2), and tumor protein 53 (TP53) genes, whereas PC-3 MVs carried increased mRNA levels of several genes including, caveolin-2 (CAV2), glutathione S-transferase pi 1 (GSTP1), pescadillo ribosomal biogenesis factor 1 (PES1), calmodulin regulated spectrin associated protein 1 (CAMSAP1), zinc-finger protein 185 (ZNF185), and others compared to PNT2 MVs. Additionally, ETS variant 1 (ETV1) and fatty acid synthase (FASN) mRNAs identified in LNCaP-and PC-3-derived MVs highly correlated with prostate cancer progression. Conclusions: Our study provides new understandings of the variability of the mRNA cargo of MVs and EXOs from different cell lines despite same cancer origin, which is essential to better understand the the proportion of the cell transcriptome that can be detected within EVs and to evaluate their role in disease diagnosis.
|
|
| 7. |
|
|
| 8. |
- Pappinen, S., et al.
(författare)
-
Organotypic cell cultures and two-photon imaging: Tools for in vitro and in vivo assessment of percutaneous drug delivery and skin toxicity
- 2012
-
Ingår i: Journal of Controlled Release. - : Elsevier BV. - 0168-3659. ; 161:2, s. 656-667
-
Tidskriftsartikel (refereegranskat)abstract
- The outermost protective layer of the skin, the stratum corneum, is responsible for skin impermeability toward external medications and potentially harmful chemicals. Stratum corneum is the target for physical and chemical approaches to enhance drug permeation. These approaches are commonly investigated in the field of drug delivery, but the drug absorption enhancement is often linked with local toxicity. In this review we are discussing two emerging technologies for drug and chemical studies in the skin: organotypic cell cultures and non-invasive two-photon microscopic imaging. Even though several cell culture based 'skin equivalents' have been introduced and validated for skin irritation testing, they are usually leaky and inadequately characterized in terms of permeation. Rat epidermal culture model (ROC) has been thoroughly characterized and it shows comparable barrier properties with the human skin thereby being useful in drug permeation and toxicity studies. In vitro and in vivo visualizations of permeants and skin structures are now feasible due to the rapid development of two-photon microscopy that allows improved depth scanning and direct in vivo visualization of the permeating compounds and adverse reactions in the skin structures. In summary, the new tools in percutaneous drug delivery studies will provide new insights to the permeation process and local toxicity. These tools may facilitate development of effective and safe transdermal drug delivery methods. (c) 2012 Elsevier B.V. All rights reserved.
|
|
